ethyl pyruvate has been researched along with Neoplasm Metastasis in 1 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 1 (100.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Beer-Stolz, D; Davé, SH; DeMarco, RA; Fink, MP; Li, F; Lotze, MT; Matsuoka, K; Plevy, SE; Sepulveda, AR; Tilstra, JS | 1 |
1 other study(ies) available for ethyl pyruvate and Neoplasm Metastasis
Article | Year |
---|---|
Ethyl pyruvate decreases HMGB1 release and ameliorates murine colitis.
Topics: Adenocarcinoma; Animals; Annexin A5; Apoptosis; Cell Line, Tumor; Cell Proliferation; Cell Survival; Colitis; Colonic Neoplasms; Cytokines; Dose-Response Relationship, Drug; Drug Administration Schedule; Female; Fluorescein-5-isothiocyanate; HMGB1 Protein; In Situ Nick-End Labeling; Interleukin-10; Interleukin-12 Subunit p40; Intestinal Mucosa; Liver Neoplasms; Mice; Mice, Inbred C57BL; Mice, Knockout; Microtubule-Associated Proteins; Neoplasm Metastasis; Neoplasm Transplantation; Nitric Oxide; Poly (ADP-Ribose) Polymerase-1; Poly(ADP-ribose) Polymerases; Pyruvates; Random Allocation; Receptor for Advanced Glycation End Products; Receptors, Immunologic; Transfection | 2009 |